Abstract:The innovative receptor engineering strategy inspects the effect of increased cationizations on US sensitivity. Abundant ROS‐mediated mitochondrial oxidative stress triggers satisfactory ICD, which further promotes the combination of SDT and ICD. Moreover, a nanosystem of AIE sonosensitizer with pH‐responsive is constructed, which obtain remarkably enhanced SDT‐mediated anti‐tumor therapy and ICD‐inducing ability in vitro and vivo, and incite systemic immune response. Benefit from the deeper penetration of mechanical wave, ultrasound (US)‐based sonodynamic therapy (SDT) executes gratifying efficacy in treating deep‐seated tumors. Nevertheless, the complicated mechanism of SDT undeniably hinders the exploration of ingenious sonosensitizers. Herein, a receptor engineering strategy of aggregation‐induced emission (AIE) sonosensitizers (TPA‐Tpy) with acceptor (A)‐donor (D)‐A' structure is proposed, which inspects the effect of increased cationizations on US sensitivity. Under US stimulation, enhanced cationization in TPA‐Tpy improves intramolecular charge transfer (ICT) and accelerates charge separation, which possesses a non‐negligible promotion in type I reactive oxygen species (ROS) production. Moreover, abundant ROS‐mediated mitochondrial oxidative stress triggers satisfactory immunogenic cell death (ICD), which further promotes the combination of SDT and ICD. Subsequently, subacid pH‐activated nanoparticles (TPA‐Tpy NPs) are constructed with charge‐converting layer (2,3‐dimethylmaleic anhydride‐poly (allylamine hydrochloride)‐polyethylene glycol (DMMA‐PAH‐PEG)) and TPA‐Tpy, achieving the controllable release of sonosensitizers. In vivo, TPA‐Tpy‐mediated SDT effectively initiates the surface‐exposed of calreticulin (ecto‐CRT), dendritic cells (DCs) maturation, and CD8+ T cell infiltration rate through enhanced ROS production, achieving suppression and ablation of primary and metastatic tumors. This study provides new opinions in regulating acceptors with eminent US sensitization, and brings a novel ICD sono‐inducer based on SDT to realize superior antitumor effect.

Sonosensitized Aggregation-Induced Emission Dots with Capacities of Immunogenic Cell Death Induction and Multivalent Blocking of Programmed Cell Death-Ligand 1 for Amplified Antitumor Immunotherapy

Sonodynamic Therapy‐Driven Immunotherapy: Constructing AIE Organic Sonosensitizers Using an Advanced Receptor‐Regulated Strategy

Evoking Robust Immunogenic Cell Death by Synergistic Sonodynamic Therapy and Glucose Depletion Using Au Clusters/single Atoms Modified TiO2 Nanosheets

Tumor-targeted AIE polymeric micelles mediated immunogenic sonodynamic therapy inhibits cancer growth and metastasis

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy

Transformable Nanosensitizer with Tumor Microenvironment‐Activated Sonodynamic Process and Calcium Release for Enhanced Cancer Immunotherapy

Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy

An acid-engineered sericin nanoplatform enhances photothermal conversion and chemotherapy outcome for inducing immunogenic cell death

Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy

Peptide Supramolecular Assembly‐Instructed in Situ Self‐Aggregation for Stratified Targeting Sonodynamic Therapy Enhancement of AIE Luminogens

Sonogenetic nanosystem activated mechanosensitive ion channel to induce cell apoptosis for cancer immunotherapy

Peptide-Appended Nanosonosensitizers Targeting Tumor Glycolysis for Synergistic Sonodynamic-Immunometabolic Therapy of Spinal-Metastasized Tumors

AIEgen-coupled Upconversion Nanoparticles Eradicate Solid Tumors Through Dual-Mode ROS Activation

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

A Carrier-free Peptide Co-assembled System with Synergistic Antitumor Effect Combines Immunotherapy and Sonodynamic Therapy

Ultrasound-Triggered Azo Free Radicals for Cervical Cancer Immunotherapy.

Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy

Albumin-based co-loaded sonosensitizer and STING agonist nanodelivery system for enhanced sonodynamic and immune combination antitumor therapy

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity

Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress Using an AIE Luminogen with a Twisted Molecular Structure.

Peptide‐appended Nanosonosensitizers Targeting Tumor Glycolysis for Synergistic Sonodynamic‐Immunometabolic Therapy of Spinal‐Metastasized Tumor